Profile
ACIU VRTX REGN ALNY SGEN ARGX
Company Name AC Immune S.A. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $205.80M $117.98B $59.32B $43.28B $43.15B $40.50B
Employees 0.13K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Andrea Pfeifer Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
ACIU VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 4
Quant Rating Sell Sell Buy Strong Sell Neutral Buy
Trading
ACIU VRTX REGN ALNY SGEN ARGX
Last Close $2.14 $366.54 $563 $438.93 $228.74 $661.83
High 52 $3.78 $516.74 $1201.76 $438.93 $228.74 $690.32
Low 52 $1.48 $366.54 $482.92 $224.58 $228.74 $514.23
Price vs. 52 Week High -43.39 % -29.07 % -53.15 % 0 % 0 % -4.13 %
Price vs. 52 Week Low 44.59 % 0 % 16.58 % 95.44 % 0 % 28.7 %
Total Return
ACIU VRTX REGN ALNY SGEN ARGX
1 Month Return 2.88 % -23.47 % 1.9 % 36.86 % 0 % 19.21 %
3 Month Return 27.38 % -13.75 % 6.67 % 74.77 % 0 % 20.41 %
6 Month Return -20.3 % -21.9 % -20.65 % 58.92 % 0 % 2.35 %
9 Month Return -33.13 % -29.07 % -32.04 % 58.21 % 0 % 11.05 %
YTD Return -20.74 % -8.98 % -20.96 % 86.53 % 0 % 7.61 %
1 Year Return -34.76 % -21.75 % -50.23 % 62.86 % 0 % 23.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 66.77 % -3.53 % 4.37 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Growth
ACIU VRTX REGN ALNY SGEN ARGX
Asset Growth 26.31 % -0.87 % 14.15 % 10.71 % -1.21 % 36.55 %
Gross Profit Growth 168.61 % 10.25 % 8.23 % 26.81 % 22.93 % 77.08 %
Revenue Growth 84.51 % 11.66 % 8.27 % 22.97 % 24.65 % 78.6 %
Revenue 3 Year - 45.6 % -13.44 % 147.1 % 91.56 % 275.84 %
Revenue 5 Year -82.58 % 163.93 % 82.78 % 775.72 % 215.48 % 1701.04 %
Revenue 10 Year -49.87 % 1632.15 % 429.43 % 2487.4 % 494.04 % 5950.81 %
EBIT Growth 6.04 % -93.69 % 13.17 % 24.59 % - 128.87 %
Net Income Growth 6.12 % -114.8 % 11.61 % 36.82 % 9.51 % 382.34 %
Net Income 3 Yeari Growth Per Share 47.56 % -122.89 % -46.47 % 69.73 % -763.59 % 274.39 %
Net Income 5 Yeari Growth Per Share -179.35 % -145.38 % 111.07 % 73.13 % -276.93 % 396.61 %
Net Income 10 Yeari Growth Per Share -363.33 % 33.84 % 1232.49 % 55.09 % -624.16 % 938.02 %
Operating Income Growth 2.32 % -106.08 % -1.39 % 37.31 % 10.13 % 94.91 %
Operating Cash Flow Growth (CFG) 209 % -113.93 % -3.78 % -107.98 % 9.07 % 80.31 %
Operating 3 Year CFG 175.36 % -118.65 % -38.85 % 98.8 % -147.99 % 88.36 %
Operating 5 Year CFG -15.56 % -131.3 % 84.11 % 97.44 % -195.86 % -135.21 %
Operating 10 Year CFG 307.6 % 12.43 % 517.51 % 97.08 % -2622.09 % -64 %
EPS Growth 20.31 % -114.8 % 10.39 % 38.64 % 10.81 % 369.77 %
EPS Diluted Growth 20.31 % -114.97 % 10.27 % 38.64 % 10.81 % 347.67 %
Book Value Per Share -40.63 % -6.59 % 11.76 % 129.75 % -9.83 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -63.61 % 62.6 % 53.21 % -89.42 % 33.72 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -70.82 % 168.85 % 167.88 % -96.01 % 220.81 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 165.84 % 1265.7 % 1113.59 % -95.83 % 691.19 % 1039.11 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -
Debt Growth 55.19 % 116.42 % 0.06 % 2.27 % -23.28 % 95.27 %
Free Cash Flow Growth 206.63 % -124.1 % -0.08 % -201.54 % 3.67 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
ACIU VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 39.44 % 86.03 % 87.44 % 86.01 % 79.1 % 65.32 %
Return on Assets TTM -24.67 % -4.32 % 11.67 % -6.4 % -16.61 % 15.06 %
Return on Equity TTM -45.22 % -6.25 % 14.43 % -509.33 % -20.8 % 18.96 %
Return on Capital Employed TTM -46.21 % -3.89 % 11.12 % -3.68 % -21.46 % 5.04 %
Net Income Per EBT TTM 100.01 % 329.41 % 91.46 % 75.89 % 101.33 % 237.3 %
EBT Per Ebit TTM 100.77 % 40.44 % 126.92 % 308.03 % 98.26 % 147.38 %
EBIT Per Revenue TTM -182.62 % -6.69 % 27.02 % -4.91 % -31.24 % 13.47 %
Cash Flow To Debt Ratio TTM 888.93 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Receivables Turnover TTM 9.71 6.15 2.53 5.62 3.91 1.91
Payables Turnover TTM 7.17 3.49 2.47 3.37 1.97 0.88
Inventory Turnover TTM - 1.14 0.56 5.01 0.96 2.21
Fixed Asset Turnover TTM 356.1 % 421.34 % 293.64 % 337.41 % 665.41 % 5009.77 %
Asset Turnover TTM 13.41 % 48.51 % 37.19 % 55.72 % 53.41 % 31.97 %
Operating Cash Flow Per Share TTM 0.46 -3.82 45.13 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM 0.45 -4.9 36.58 -0.58 -2.88 -1.09
Cash Per Share TTM 145.02 % 2413.86 % 7107.14 % 2024.29 % 939.52 % 5536.58 %
Operating Cash Flow Sales Ratio TTM 162.56 % -8.83 % 33.37 % -1.92 % -23.12 % -3.31 %
Free Cash Flow Operating Cash Flow Ratio TTM 98.5 % 128.33 % 81.05 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM 888.93 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Price To Free Cash Flows Ratio TTM 3.67 -93.78 15.43 -574.08 -81.26 -521.84
Price To Operating Cash Flows Ratio TTM 3.67 -120.39 12.38 -954.11 -93.1 -618.62
Price Cash Flow Ratio TTM 3.67 -120.39 12.38 -954.11 -93.1 -618.62
Income Statement (TTM)
ACIU VRTX REGN ALNY SGEN ARGX
Revenue $0.03B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0.03B $9.49B $11.75B $1.92B $1.55B $1.96B
Gross Profit Ratio 100% 86.11% 82.74% 85.62% 79.1% 89.62%
EBITDA $-0.05B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.05B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -0.51 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
ACIU VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $2.7B $1.25B $0.04B $0.03B
Total Liabilities $0.12B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.11B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0.13B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.01B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.23B $22.53B $37.76B $4.24B $3.67B $6.2B
Cash Flow Statement (TTM)
ACIU VRTX REGN ALNY SGEN ARGX
Net Income $-0.05B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0.07B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.95
AARD Aardvark Therapeutics, Inc. Common Stock 11.99
ABCL AbCellera Biologics Inc. 4.25
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.26
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.36
ABPWW 0.0368
ABSI Absci Corporation 2.84
ABUS Arbutus Biopharma Corporation 3.4
ABVC ABVC BioPharma, Inc. 2.7
ABVX Abivax SA American Depositary Shares 70.13
ACAD ACADIA Pharmaceuticals Inc. 24.6
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.621
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.5
ACLX Arcellx, Inc. 70.5
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.01535 132.04
GWX SPDR S&P International Small Cap ETF 0.02 38.62
BIB ProShares Ultra Nasdaq Biotechnology 0.0156637 50.7955
SBIO ALPS Medical Breakthroughs ETF 0.002 32.705
BMED BlackRock Future Health ETF 0.0106 24.81
IBBQ Invesco Nasdaq Biotechnology ETF 0.023 22.3738
DFAT Dimensional U.S. Targeted Value ETF 0.00030463 54.58
DFAS Dimensional U.S. Small Cap ETF 0.00000797 64.48
DFAC Dimensional U.S. Core Equity 2 ETF 0.00004569 36.81
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02197 5.568
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02197 6.495
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0233 39.775
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.02197 6.464
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0233 46.4
QQQS Invesco NASDAQ Future Gen 200 ETF 0.406 27.9878
DFSU Dimensional US Sustainability Core 1 ETF 0.00026094 40.44
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02197 4.829
DXUV Dimensional ETF Trust 0.00002414 55.628
Unlock